| Application no. and date | 20764690.2 (espacenet) (Federated) (European Patent Register), 20200905 | | Patent/reg. no. and date | DK/EP 4025235, 20260225 | | Publication date | 20220713 | | Priority no. and date | EP 19195793, 20190906 | | EP pub. no. and date |
EP 4025235 20220713 | | Effective date | | | Applicant/owner | Novaliq GmbH, Im Neuenheimer Feld 515
69120 Heidelberg, DE | | Applicant ref. no. | | | Inventor | BEIER, Markus, Marc-Aurel-Weg 20
69469 Weinheim, DE,
LÖSCHER, Frank, Burgweg 31
69198 Schriesheim, DE,
Leo, Chiara Silvana, Bahnhofstrasse 7
69115 Heidelberg, DE,
HAISSER, Jörg, Jahnstrasse 2
74936 Siegelsbach, DE | | Representative | | | Opponent | | | IPC Class | A61K 38/13 (2006.01) , A61K 47/06 (2006.01) , A61K 47/10 (2017.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 27/02 (2006.01) , A61P 31/02 (2006.01) | | Title | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITIS | | Int. application no. | EP2020074884 | | Int. publication no. | WO2021044045 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
